HANDOK Inc. (KRX:002390)

Market Cap	150.70B -10.0%
Revenue (ttm)	516.37B +0.7%
Net Income	-43.54B
EPS	-3,162.37
Shares Out	12.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (1.77%)
Ex-Dividend Date	Feb 26, 2026

Volume	62,618
Average Volume	23,523
Open	11,230
Previous Close	11,290
Day's Range	11,230 - 11,620
52-Week Range	10,500 - 14,250
Beta	0.40
RSI	54.92
Earnings Date	Feb 6, 2026

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The co...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 940
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 002390

Financial Performance

In 2024, HANDOK's revenue was 507.36 billion, a decrease of -2.94% compared to the previous year's 522.74 billion. Losses were -52.56 billion, 82.5% more than in 2023.